Sbi Securities Co., Ltd. Phathom Pharmaceuticals, Inc. Transaction History
Sbi Securities Co., Ltd.
- $3 Trillion
- Q1 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 50 shares of PHAT stock, worth $435. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50Holding current value
$435% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PHAT
# of Institutions
150Shares Held
66.5MCall Options Held
94KPut Options Held
55.5K-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.1MShares$88.1 Million3.99% of portfolio
-
Medicxi Ventures Management (Jersey) LTD7.46MShares$65 Million20.28% of portfolio
-
Jennison Associates LLC7.04MShares$61.3 Million0.03% of portfolio
-
Invesco Ltd. Atlanta, GA3.65MShares$31.8 Million0.0% of portfolio
-
Carlyle Group Inc. Washington, DC3.5MShares$30.5 Million27.15% of portfolio
About Phathom Pharmaceuticals, Inc.
- Ticker PHAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,175,200
- Market Cap $341M
- Description
- Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...